Other specified pulmonary heart diseases
ICD-10 I27.89 is a billable code used to indicate a diagnosis of other specified pulmonary heart diseases.
I27.89 refers to 'Other specified pulmonary heart diseases,' which encompasses a range of conditions affecting the right side of the heart due to pulmonary issues. Clinically, these conditions may present with symptoms such as dyspnea, fatigue, and chest pain, often exacerbated by exertion. The anatomy involved primarily includes the right ventricle and pulmonary arteries, which may become hypertrophied or dilated in response to increased pressure from pulmonary hypertension or other underlying lung diseases. Disease progression can vary widely; some patients may experience gradual worsening of symptoms, while others may have acute exacerbations. Diagnostic considerations include echocardiography, chest X-rays, and pulmonary function tests to assess right heart function and pulmonary status. It is crucial to differentiate I27.89 from other pulmonary heart diseases, such as pulmonary hypertension (I27.0) and cor pulmonale (I27.1), to ensure accurate diagnosis and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I27.89 includes various pulmonary heart diseases not classified elsewhere, such as certain forms of pulmonary hypertension, right heart failure due to lung disease, and other specified conditions affecting the right heart due to pulmonary issues.
I27.89 should be used when the pulmonary heart disease does not fit the criteria for more specific codes like I27.0 or I27.1, particularly when the condition is not fully defined or is multifactorial.
Documentation should include a comprehensive clinical evaluation, results from echocardiograms, pulmonary function tests, and any relevant imaging studies that support the diagnosis of other specified pulmonary heart diseases.
